Kirsten Jensen, NP
Nurse Practitioner · Wailuku, HINPI 1932350717
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 33.2% of the total. 2025 is the largest year on record at $538, more than ten times the $26 reported in 2022.
Across 28 payments — averaging $28.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$263
- Ardelyx, Inc.$200
- Bristol Myers Squibb$81
- Calliditas Therapeutics US Inc.$66
- Travere Therapeutics, Inc.$60
- AstraZeneca$39
- plus $83 from 3 others
What the payments were for
- Food & beverage$788100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $263 |
| Ardelyx, Inc. | 11 | $200 |
| Bristol Myers Squibb | 5 | $81 |
| Calliditas Therapeutics US Inc. | 2 | $66 |
| Travere Therapeutics, Inc. | 3 | $60 |
| AstraZeneca | 2 | $39 |
| Akebia Therapeutics Inc | 1 | $30 |
| Novartis | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TERLIVAZ$263
How this compares
$791 in reported general payments places this provider in the 75th percentile of 215 nurse practitioner providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 32 | $102,694 |
| JardianceEmpagliflozin | 38 | $31,460 |
| Sevelamer Carbonate | 109 | $19,712 |
| Atorvastatin Calcium | 23 | $865 |
| Torsemide | 13 | $611 |
| Losartan Potassium | 44 | $564 |
| Lisinopril | 15 | $416 |
| Amlodipine Besylate | 32 | $356 |
| Nifedipine ErNifedipine | 14 | $349 |
| Hydralazine Hcl | 12 | $176 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $166 |
| Furosemide | 34 | $139 |
| Allopurinol | 14 | $136 |
| Carvedilol | 22 | $59 |
| Sertraline Hcl | 18 | $36 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Wailuku
- Rosemarie ForondaWailuku$15K
- Ralph DomingoWailuku$2K
- Kimi PrenticeEwa Beach$65K
- Ashley SpringerHonolulu$43K
- Sung JungHonolulu$29K
- Judy KoHonolulu$17K
- Joanna AgenaAiea$16K
- Bryce MontalboHonolulu$15K
- Anitalei AlexioAiea$11K
- Rita AbreuHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.